CEL-SCI Corporation to Present at the Noble Financial Capital Markets’ 12th Annual Investor Conference
January 14 2016 - 9:00AM
Business Wire
CEL-SCI Corporation (NYSE MKT: CVM), a Phase 3 cancer
immunotherapy company, today announced that its Chief Executive
Officer, Geert Kersten, will present at the NobleCon12 - Noble
Financial Capital Markets’ Twelfth Annual Investor Conference at
Club Med in Sandpiper Bay, Florida, on Tuesday, January 19th at
3:00 p.m. Eastern Standard Time.
Following the Conference on January 22, 2016, a video webcast of
CEL-SCI’s presentation will be available on the Company's web site
www.cel-sci.com/investor_relations.html, or as part of a complete
catalog of presentations available at Noble Financial websites:
www.noblefcm.com, or www.nobleconference.com. The webcast and
presentation will be archived on the Company's website and on the
Noble websites for 90 days following the event.
About CEL-SCI Corporation
CEL-SCI is a Phase 3 immunotherapy company with platform
technologies that can potentially treat a variety of cancers and
viral diseases. We believe that one must activate the immune system
BEFORE radiation and chemotherapy, and even before surgery, to
achieve the best results in the greatest number of patients.
CEL-SCI is conducting a Phase 3 trial in 24 countries of Multikine
(Leukocyte Interleukin Injection) for the treatment of head and
neck cancer, which accounts for about 6% of cancers globally and a
$6 billion market. Over 668 patients are already enrolled in this
study. CEL-SCI is also testing Multikine with the U.S. Navy in HIV
infected patients with HPV related diseases. CEL-SCI has
development partnerships with Teva Pharmaceuticals, Orient
EuroPharma of Taiwan, Ergomed and the NIH. The Company operates its
own 75,000 sq. ft. manufacturing facility and produces Multikine
for its clinical trials. When fully built out, this facility will
have the capacity to supply about $3 billion worth of Multikine
annually. CEL-SCI is also developing its pre-clinical L.E.A.P.S.
(Ligand Epitope Antigen Presentation System) technology as a
potential vaccine for the treatment of rheumatoid arthritis.
The Company has operations in Vienna, Virginia, and in/near
Baltimore, Maryland.
About Noble Financial Capital Markets
Noble Financial Capital Markets established in 1984, is an
equity-research driven, full-service, investment & merchant
banking boutique focused on the healthcare, media &
entertainment, technology and natural resources sectors. The
company has offices in Boca Raton, New York, Boston and Los
Angeles. In addition to the annual multi-sector NobleCon, each year
Noble hosts numerous “non-deal” corporate road shows and
sector-specific conferences. Members: FINRA, SIPC, MSRB.
www.noblefcm.com
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160114005637/en/
CEL-SCI CorporationGavin de Windt, 703-506-9460
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Apr 2023 to Apr 2024